Growth Metrics

Evolent Health (EVH) Net Cash Flow (2016 - 2026)

Evolent Health has reported Net Cash Flow over the past 11 years, most recently at $37.9 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 25.33% year-over-year to $37.9 million; the TTM value through Dec 2025 reached $2.7 million, up 106.0%, while the annual FY2025 figure was $2.7 million, 106.0% up from the prior year.
  • Net Cash Flow for Q4 2025 was $37.9 million at Evolent Health, up from -$34.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $99.3 million in Q1 2025 and troughed at -$99.8 million in Q2 2025.
  • A 5-year average of -$9.0 million and a median of $4.5 million in 2023 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: plummeted 4814.19% in 2021 and later surged 5063.93% in 2024.
  • Year by year, Net Cash Flow stood at $73.2 million in 2021, then plummeted by 72.15% to $20.4 million in 2022, then tumbled by 105.02% to -$1.0 million in 2023, then surged by 5063.93% to $50.8 million in 2024, then decreased by 25.33% to $37.9 million in 2025.
  • Business Quant data shows Net Cash Flow for EVH at $37.9 million in Q4 2025, -$34.8 million in Q3 2025, and -$99.8 million in Q2 2025.